Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 March 2021 | Story Dr Nitha Ramnath
Francois van Schalkwyk, Keenan Carelse, UFS Alumni, Bertus Jacobs, UFS, University of the Free State, alumni relations, IoT.nxt.

We are pleased to host Bertus Jacobs in our second episode of the Voices of the Free State podcast series. As Chief Technology Officer at IoT.nxt. (Internet of Things), Bertus’ mind is constantly searching for new techniques, and imparting these to his team of developers. Evident from his ‘always on’ approach, Jacobs has optimised his passion for turning ideas into mainstream realities. He co-founded a successful software company, CSS Software, which saw its humble beginnings grow from Bloemfontein-based to an international-footprinted company. CSS Software is regarded as having some of the most innovative products in its market segment and was acquired by a JSE-listed group.

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series.  Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021.  Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important. The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them. 

Listen to the podcast: 

Our podcast guest

While studying towards his BScHons (Computer Science) at the University of the Free State, Bertus developed an SDK (Software Development Kit) with low-level integration into various graphics hardware.  

Bertus has researched many ways of contributing to the growing IT industry – from developing point-of-sale systems that still run today, qualifying as MCP and MCSE, engineering telematic and biometric solutions for clients (UFS was one of them). After being approached to consult in developing a solution for the government, his search for a certain hardware problem and his expertise in the IT realm resulted in his invention of a controller and the birth of the RAPTOR.  Reports that took eight weeks to compile previously, are now at the fingertips of those who need it – all through data harvesting and dashboarding that combines software and hardware. The world-changing RAPTOR delivers a complete IoT solution, which has been internationally validated as being at the forefront of the emerging IoT wave.  IoT.nxt was named Best Commercial and Best Overall Winner at the MTN Business M2M Awards in 2017.  

Stay tuned for episode three to be released on 5 April 2021. 

For further information regarding the podcast series, or to propose other alumni guests, please email us at alumnipodcast@ufs.ac.za 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept